Chongqing Lummy Pharmaceutical (SZSE:300006) ROCE % : -11.44% (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chongqing Lummy Pharmaceutical's annualized ROCE % for the quarter that ended in Dec. 2024 was -11.44%.

Chongqing Lummy Pharmaceutical ROCE % Historical Data

The historical data trend for Chongqing Lummy Pharmaceutical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Lummy Pharmaceutical ROCE % Chart

Chongqing Lummy Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-16.17

-3.98

-2.38

0.69

-2.94

Chongqing Lummy Pharmaceutical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															12.35	0.75	3.07	-4.36	-11.44

Chongqing Lummy Pharmaceutical ROCE % Calculation

Chongqing Lummy Pharmaceutical's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-64.407	/	( ( (2890.88 - 562.272)	+	(2855.8 - 801.613) )	/ 2 )
	=	-64.407	/	( (2328.608	+	2054.187)	/ 2 )
	=	-64.407	/	2191.3975
	=	-2.94 %

Chongqing Lummy Pharmaceutical's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-246.408	/	( ( (3036.777 - 781.896)	+	(2855.8 - 801.613) )	/ 2 )
	=	-246.408	/	( ( 2254.881	+	2054.187 )	/ 2 )
	=	-246.408	/	2154.534
	=	-11.44 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Chongqing Lummy Pharmaceutical (SZSE:300006) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chongqing Lummy Pharmaceutical ROCE % Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Lummy Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Yuma Road, Nan'an District, chongqing, CHN, 401123

Website

http://www.cqlummy.com

Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.

Executives

Lai Wen	Executives
Yuan Yuan	Supervisors
Qiu Yu	Directors, executives
Leng Xue Feng	Secretary, Director
Zhang Xiao Xue	Supervisors
Wang Ying	Director
Zhou Xue Mei	Supervisors
Zhao Bin	Executives
Tang Xiao Hai	Executives
Fu Rong	Executives
Li Xian Feng	Supervisors
Qiu Wei	Director

Chongqing Lummy Pharmaceutical Headlines

No Headlines